Independent register of U.S. FDA drug recalls · updated Oct 11, 2026
RxRecalls Get alerts

Ongoing drug recalls - open right now

Every FDA drug recall whose status is still Ongoing: the firm is still removing product from the market, or the FDA has not yet closed the file. Some were opened years ago and never formally terminated, so check the initiation date as well as the status.

2,760 recalls, newest first.

Class I · High risk

Weiner Boner Honey

Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.

Ongoing Chemical / undeclared Pyramids Wholesale Inc. D-0449-2024
Class I · High risk

Spanish Fly 22K capsules

Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.

Ongoing Chemical / undeclared Pyramids Wholesale Inc. D-0448-2024
Class II · Moderate risk

Febuxostat Tablets 80mg

CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.

Ongoing Microbial contamination Sun Pharmaceutical Industries INC NDC 16714-060-01 D-0369-2024
Class II · Moderate risk

Febuxostat Tablets 40mg

CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.

Ongoing Microbial contamination Sun Pharmaceutical Industries INC NDC 16714-059-01 D-0368-2024
Class II · Moderate risk

FentaNYL citrate

Lack of Assurance of Sterility: Firm did not perform process validation.

Ongoing Sterility / contamination SSM Health Care St. Louis DBA SSM St. Clare Health Center D-0436-2024
Class II · Moderate risk

Phenylephrine HCl

Lack of Assurance of Sterility: Firm did not perform process validation.

Ongoing Sterility / contamination SSM Health Care St. Louis DBA SSM St. Clare Health Center D-0435-2024
Class III · Low risk

Clindamycin Phosphate

Defective Container: Out of specification for weight due to a slow leakage at the 12-month stability timepoint.

Ongoing Packaging defect Contract Pharmaceuticals Limited Canada NDC 10135-0691-61 D-0364-2024
Class II · Moderate risk

Lidocaine HCL 1%

Presence of Particulate Matter: glass vials from the manufacturer showed signs of glass delamination.

Ongoing Particulate / foreign matter Denver Solutions, LLC DBA Leiters Health NDC 71449-090-42 D-0363-2024
Class II · Moderate risk

Moxifloxacin 5mg/ml

Presence of Particulate Matter: glass vials from the manufacturer showed signs of glass delamination.

Ongoing Particulate / foreign matter Denver Solutions, LLC DBA Leiters Health NDC 71449-097-42 D-0362-2024

Recalls by year